Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 499

1.

Neuroimmune crosstalk in the pathophysiology of hypertension.

Calvillo L, Gironacci MM, Crotti L, Meroni PL, Parati G.

Nat Rev Cardiol. 2019 Mar 20. doi: 10.1038/s41569-019-0178-1. [Epub ahead of print] Review.

PMID:
30894678
2.

First Report of the Italian Registry on Immune-Mediated Congenital Heart Block (Lu.Ne Registry).

Fredi M, Andreoli L, Bacco B, Bertero T, Bortoluzzi A, Breda S, Cappa V, Ceccarelli F, Cimaz R, De Vita S, Di Poi E, Elefante E, Franceschini F, Gerosa M, Govoni M, Hoxha A, Lojacono A, Marozio L, Mathieu A, Meroni PL, Minniti A, Mosca M, Muscarà M, Padovan M, Piga M, Priori R, Ramoni V, Ruffatti A, Tani C, Tonello M, Trespidi L, Zatti S, Calza S, Tincani A, Brucato A.

Front Cardiovasc Med. 2019 Feb 28;6:11. doi: 10.3389/fcvm.2019.00011. eCollection 2019.

3.

Interleukin-17/Interleukin-21 and Interferon-g producing T cells specific for β2 Glycoprotein I in atherosclerosis inflammation of systemic lupus erythematosus patients with antiphospholipid syndrome.

Benagiano M, Borghi MO, Romagnoli J, Mahler M, Della Bella C, Grassi A, Capitani N, Emmi G, Troilo A, Silvestri E, Emmi L, Alnwaisri H, Bitetti J, Tapinassi S, Prisco D, Baldari CT, Meroni PL, D'Elios MM.

Haematologica. 2019 Mar 14. pii: haematol.2018.209536. doi: 10.3324/haematol.2018.209536. [Epub ahead of print]

4.

Editorial: Systemic Lupus Erythematosus and Antiphospholipid Syndrome.

Meroni PL, Tsokos GC.

Front Immunol. 2019 Feb 25;10:199. doi: 10.3389/fimmu.2019.00199. eCollection 2019. No abstract available.

5.

Certified reference material against PR3 ANCA IgG autoantibodies. From development to certification.

Monogioudi E, Sheldon J, Meroni PL, Hutu DP, Schimmel H, Zegers I; Committee for the Harmonisation of Autoimmune Testing (C-HAT) of the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC).

Clin Chem Lab Med. 2019 Feb 21. pii: /j/cclm.ahead-of-print/cclm-2018-1095/cclm-2018-1095.xml. doi: 10.1515/cclm-2018-1095. [Epub ahead of print]

PMID:
30789822
6.

P2X7 receptor restrains pathogenic Tfh cell generation in systemic lupus erythematosus.

Faliti CE, Gualtierotti R, Rottoli E, Gerosa M, Perruzza L, Romagnani A, Pellegrini G, De Ponte Conti B, Rossi RL, Idzko M, Mazza EMC, Bicciato S, Traggiai E, Meroni PL, Grassi F.

J Exp Med. 2019 Feb 4;216(2):317-336. doi: 10.1084/jem.20171976. Epub 2019 Jan 17.

PMID:
30655308
7.

"Disease knowledge index" and perspectives on reproductive issues: A nationwide study on 398 women with autoimmune rheumatic diseases.

Andreoli L, Lazzaroni MG, Carini C, Dall'Ara F, Nalli C, Reggia R, Rodrigues M, Benigno C, Baldissera E, Bartoloni-Bocci E, Basta F, Bellisai F, Bortoluzzi A, Campochiaro C, Cantatore FP, Caporali R, Ceribelli A, Chighizola CB, Conigliaro P, Corrado A, Cutolo M, D'Angelo S, De Stefani E, Doria A, Favaro M, Fischetti C, Foti R, Gabrielli A, Generali E, Gerli R, Gerosa M, Larosa M, Maier A, Malavolta N, Meroni M, Meroni PL, Montecucco C, Mosca M, Padovan M, Paolazzi G, Pazzola G, Peccatori S, Perricone R, Pettiti G, Picerno V, Prevete I, Ramoni V, Romeo N, Ruffatti A, Salvarani C, Sebastiani GD, Selmi C, Serale F, Sinigaglia L, Tani C, Trevisani M, Vadacca M, Valentini E, Valesini G, Visalli E, Vivaldelli E, Zuliani L, Tincani A.

Joint Bone Spine. 2018 Dec 21. pii: S1297-319X(18)30257-4. doi: 10.1016/j.jbspin.2018.12.002. [Epub ahead of print]

PMID:
30579917
8.

Disease activity assessment of rheumatic diseases during pregnancy: a comprehensive review of indices used in clinical studies.

Andreoli L, Gerardi MC, Fernandes M, Bortoluzzi A, Bellando-Randone S, Brucato A, Caporali R, Chighizola CB, Chimenti MS, Conigliaro P, Cutolo M, Cutro MS, D'Angelo S, Doria A, Elefante E, Fredi M, Galeazzi M, Gerosa M, Govoni M, Iuliano A, Larosa M, Lazzaroni MG, Matucci-Cerinic M, Meroni M, Meroni PL, Mosca M, Patanè M, Pazzola G, Pendolino M, Perricone R, Ramoni V, Salvarani C, Sebastiani GD, Selmi C, Spinelli FR, Valesini G, Scirè CA, Tincani A.

Autoimmun Rev. 2019 Feb;18(2):164-176. doi: 10.1016/j.autrev.2018.08.008. Epub 2018 Dec 18. Review.

PMID:
30572134
9.

Detection of anti-adalimumab antibodies in a RA responsive cohort of patients using three different techniques.

Real-Fernández F, Pregnolato F, Cimaz R, Papini AM, Borghi MO, Meroni PL, Rovero P.

Anal Biochem. 2019 Feb 1;566:133-138. doi: 10.1016/j.ab.2018.11.018. Epub 2018 Nov 22.

PMID:
30471243
10.

New insight into antiphospholipid syndrome: antibodies to β2glycoprotein I-domain 5 fail to induce thrombi in rats.

Durigutto P, Grossi C, Borghi MO, Macor P, Pregnolato F, Raschi E, Myers MP, de Groot PG, Meroni PL, Tedesco F.

Haematologica. 2018 Nov 15. pii: haematol.2018.198119. doi: 10.3324/haematol.2018.198119. [Epub ahead of print]

11.

Reply to: Vaccination for hepatitis B virus in an Australian pre-biologic population with rheumatoid arthritis.

Meroni PL, Zavaglia D, Girmenia C.

Clin Exp Rheumatol. 2019 Jan-Feb;37(1):164. Epub 2018 Sep 20. No abstract available.

12.

HIBISCUS: Hydroxychloroquine for the secondary prevention of thrombotic and obstetrical events in primary antiphospholipid syndrome.

Belizna C, Pregnolato F, Abad S, Alijotas-Reig J, Amital H, Amoura Z, Andreoli L, Andres E, Aouba A, Apras Bilgen S, Arnaud L, Bienvenu B, Bitsadze V, Blanco P, Blank M, Borghi MO, Caligaro A, Candrea E, Canti V, Chiche L, Chretien JM, Cohen Tervaert JW, Damian L, Delross T, Dernis E, Devreese K, Djokovic A, Esteve-Valverde E, Favaro M, Fassot C, Ferrer-Oliveras R, Godon A, Hamidou M, Hasan M, Henrion D, Imbert B, Jeandel PY, Jeannin P, Jego P, Jourde-Chiche N, Khizroeva J, Lambotte O, Landron C, Latino JO, Lazaro E, de Leeuw K, Le Gallou T, Kiliç L, Limper M, Loufrani L, Lubin R, Magy-Bertrand N, Mahe G, Makatsariya A, Martin T, Muchardt C, Nagy G, Omarjee L, Van Paasen P, Pernod G, Perrinet F, Pïres Rosa G, Pistorius MA, Ruffatti A, Said F, Saulnier P, Sene D, Sentilhes L, Shovman O, Sibilia J, Sinescu C, Stanisavljevic N, Stojanovich L, Tam LS, Tincani A, Tollis F, Udry S, Ungeheuer MN, Versini M, Cervera R, Meroni PL.

Autoimmun Rev. 2018 Dec;17(12):1153-1168. doi: 10.1016/j.autrev.2018.05.012. Epub 2018 Oct 12. Review.

PMID:
30316994
13.

Immediate treatment with tumour necrosis factor inhibitors in synthetic disease-modifying anti-rheumatic drugs-naïve patients with rheumatoid arthritis: results of a modified Italian Expert Consensus.

Bortoluzzi A, Valesini G, D'Angelo S, Frediani B, Bazzichi L, Afeltra A, Paolazzi G, Doria A, Meroni PL, Govoni M.

Rheumatology (Oxford). 2018 Oct 1;57(57 Suppl 7):vii32-vii41. doi: 10.1093/rheumatology/key076. Review.

PMID:
30289538
14.

Unmet Needs in the Treatment of RA in the Era of Jak-i: IDRA (Italian Delphi Rheumatoid Arthritis) Consensus.

Caporali R, Doria A, Ferraccioli GF, Meroni PL, Zavaglia D, Iannone F.

Biomed Res Int. 2018 Sep 9;2018:3878953. doi: 10.1155/2018/3878953. eCollection 2018.

15.

Factors associated with first thrombosis in patients presenting with obstetric antiphospholipid syndrome (APS) in the APS Alliance for Clinical Trials and International Networking Clinical Database and Repository: a retrospective study.

de Jesús GR, Sciascia S, Andrade D, Barbhaiya M, Tektonidou M, Banzato A, Pengo V, Ji L, Meroni PL, Ugarte A, Cohen H, Branch DW, Andreoli L, Belmont HM, Fortin PR, Petri M, Rodriguez E, Cervera R, Knight JS, Atsumi T, Willis R, Nascimento IS, Rosa R, Erkan D, Levy RA; APS ACTION.

BJOG. 2019 Apr;126(5):656-661. doi: 10.1111/1471-0528.15469. Epub 2018 Oct 24.

PMID:
30222236
16.

Immune complexes containing scleroderma-specific autoantibodies induce a profibrotic and proinflammatory phenotype in skin fibroblasts.

Raschi E, Chighizola CB, Cesana L, Privitera D, Ingegnoli F, Mastaglio C, Meroni PL, Borghi MO.

Arthritis Res Ther. 2018 Aug 29;20(1):187. doi: 10.1186/s13075-018-1689-6.

17.

Clinical, Ultrasound, and Predictability Outcomes Following Certolizumab Pegol Treatment (with Methotrexate) in Patients with Moderate-to-Severe Rheumatoid Arthritis: 52-Week Results from the CZP-SPEED Study.

Sarzi-Puttini P, Filippucci E, Adami S, Meroni PL, Batticciotto A, Idolazzi L, De Lucia O, Talavera P, Kumke T, Grassi W.

Adv Ther. 2018 Aug;35(8):1153-1168. doi: 10.1007/s12325-018-0751-8. Epub 2018 Jul 24.

18.

Gene expression profiling identifies distinct molecular signatures in thrombotic and obstetric antiphospholipid syndrome.

Ripoll VM, Pregnolato F, Mazza S, Bodio C, Grossi C, McDonnell T, Pericleous C, Meroni PL, Isenberg DA, Rahman A, Giles IP.

J Autoimmun. 2018 Sep;93:114-123. doi: 10.1016/j.jaut.2018.07.002. Epub 2018 Jul 19.

19.

Pathogenic Role of Complement in Antiphospholipid Syndrome and Therapeutic Implications.

Tedesco F, Borghi MO, Gerosa M, Chighizola CB, Macor P, Lonati PA, Gulino A, Belmonte B, Meroni PL.

Front Immunol. 2018 Jun 19;9:1388. doi: 10.3389/fimmu.2018.01388. eCollection 2018.

20.

Obstetric and vascular antiphospholipid syndrome: same antibodies but different diseases?

Meroni PL, Borghi MO, Grossi C, Chighizola CB, Durigutto P, Tedesco F.

Nat Rev Rheumatol. 2018 Jul;14(7):433-440. doi: 10.1038/s41584-018-0032-6. Review.

PMID:
29891914
21.

Primary antiphospholipid syndrome and antiphospholipid syndrome associated to systemic lupus: Are they different entities?

Belizna C, Stojanovich L, Cohen-Tervaert JW, Fassot C, Henrion D, Loufrani L, Nagy G, Muchardt C, Hasan M, Ungeheuer MN, Arnaud L, Alijotas-Reig J, Esteve-Valverde E, Nicoletti F, Saulnier P, Godon A, Reynier P, Chrétien JM, Damian L, Omarjee L, Mahé G, Pistorius MA, Meroni PL, Devreese K.

Autoimmun Rev. 2018 Aug;17(8):739-745. doi: 10.1016/j.autrev.2018.01.027. Epub 2018 Jun 6. Review.

PMID:
29885541
22.

Thrombosis and Anti-phospholipid Syndrome: a 5-Year Update on Treatment.

Chighizola CB, Meroni PL.

Curr Rheumatol Rep. 2018 May 31;20(7):44. doi: 10.1007/s11926-018-0741-5. Review.

PMID:
29850957
23.

Diagnostic laboratory tests for systemic autoimmune rheumatic diseases: unmet needs towards harmonization.

Meroni PL, Borghi MO.

Clin Chem Lab Med. 2018 Sep 25;56(10):1743-1748. doi: 10.1515/cclm-2018-0066. No abstract available.

PMID:
29708880
24.

Pitfalls of antinuclear antibody detection in systemic lupus erythematosus: the positive experience of a national multicentre study.

Pregnolato F, Borghi MO, Meroni PL; Forum Interdisciplinare per la Ricerca sulle Malattie Autoimmuni (FIRMA) Study Group.

Ann Rheum Dis. 2018 Apr 25. pii: annrheumdis-2018-213516. doi: 10.1136/annrheumdis-2018-213516. [Epub ahead of print] No abstract available.

PMID:
29695499
25.

Unending story of the indirect immunofluorescence assay on HEp-2 cells: old problems and new solutions?

Meroni PL, Chan EK, Damoiseaux J, Andrade LEC, Bossuyt X, Conrad K, Mariette X, Sheldon J, Rönnelid J, Fritzler MJ; members of the committees.

Ann Rheum Dis. 2018 Apr 17. pii: annrheumdis-2018-213440. doi: 10.1136/annrheumdis-2018-213440. [Epub ahead of print] No abstract available.

PMID:
29666046
26.

The incidence of cardiovascular events in Italian patients with systemic lupus erythematosus is lower than in North European and American cohorts: implication of disease-associated and traditional risk factors as emerged by a 16-year retrospective GIRRCS study: GIRRCS=Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale.

Fasano S, Margiotta DP, Gualtierotti R, Corrado A, Berardicurti O, Iacono D, Pierro L, Riccardi A, Giacomelli R, Cantatore FP, Meroni PL, Afeltra A, Valentini G.

Medicine (Baltimore). 2018 Apr;97(15):e0370. doi: 10.1097/MD.0000000000010370.

27.

Standardization of autoimmune testing - is it feasible?

Monogioudi E, Martos G, Hutu DP, Schimmel H, Meroni PL, Sheldon J, Zegers I.

Clin Chem Lab Med. 2018 Sep 25;56(10):1734-1742. doi: 10.1515/cclm-2017-1077. No abstract available.

28.

Lupus nephritis: low urinary DNase I levels reflect loss of renal DNase I and may be utilized as a biomarker of disease progression.

Pedersen HL, Horvei KD, Thiyagarajan D, Norby GE, Seredkina N, Moroni G, Eilertsen GØ, Holdaas H, Strøm EH, Bakland G, Meroni PL, Rekvig OP.

J Pathol Clin Res. 2018 Jul;4(3):193-203. doi: 10.1002/cjp2.99. Epub 2018 Apr 6.

29.

Successful sequential therapy with rituximab and belimumab in patients with active systemic lupus erythematosus: a case series.

Gualtierotti R, Borghi MO, Gerosa M, Schioppo T, Larghi P, Geginat J, Meroni PL.

Clin Exp Rheumatol. 2018 Jul-Aug;36(4):643-647. Epub 2018 Feb 27.

30.

Effect of Additional Treatments Combined with Conventional Therapies in Pregnant Patients with High-Risk Antiphospholipid Syndrome: A Multicentre Study.

Ruffatti A, Tonello M, Hoxha A, Sciascia S, Cuadrado MJ, Latino JO, Udry S, Reshetnyak T, Costedoat-Chalumeau N, Morel N, Marozio L, Tincani A, Andreoli L, Haladyj E, Meroni PL, Gerosa M, Alijotas-Reig J, Tenti S, Mayer-Pickel K, Simchen MJ, Bertero MT, De Carolis S, Ramoni V, Mekinian A, Grandone E, Maina A, Serrano F, Pengo V, Khamashta MA.

Thromb Haemost. 2018 Apr;118(4):639-646. doi: 10.1055/s-0038-1632388. Epub 2018 Feb 28.

PMID:
29490410
31.

Beyond thrombosis: Anti-β2GPI domain 1 antibodies identify late pregnancy morbidity in anti-phospholipid syndrome.

Chighizola CB, Pregnolato F, Andreoli L, Bodio C, Cesana L, Comerio C, Gerosa M, Grossi C, Kumar R, Lazzaroni MG, Mahler M, Mattia E, Nalli C, Norman GL, Raimondo MG, Ruffatti A, Tonello M, Trespidi L, Tincani A, Borghi MO, Meroni PL.

J Autoimmun. 2018 Jun;90:76-83. doi: 10.1016/j.jaut.2018.02.002. Epub 2018 Feb 14.

PMID:
29454510
32.

The treatment of anti-phospholipid syndrome: A comprehensive clinical approach.

Chighizola CB, Andreoli L, Gerosa M, Tincani A, Ruffatti A, Meroni PL.

J Autoimmun. 2018 Jun;90:1-27. doi: 10.1016/j.jaut.2018.02.003. Epub 2018 Feb 13. Review.

PMID:
29449131
33.

Baseline ultrasound examination as possible predictor of relapse in patients affected by juvenile idiopathic arthritis (JIA).

De Lucia O, Ravagnani V, Pregnolato F, Hila A, Pontikaki I, Gattinara M, Romano M, Gerloni V, Pieropan S, Murgo A, Rossini M, Cimaz R, Meroni PL.

Ann Rheum Dis. 2018 Oct;77(10):1426-1431. doi: 10.1136/annrheumdis-2017-211696. Epub 2018 Feb 6.

PMID:
29437586
34.

Sex and Management of Rheumatoid Arthritis.

Favalli EG, Biggioggero M, Crotti C, Becciolini A, Raimondo MG, Meroni PL.

Clin Rev Allergy Immunol. 2018 Jan 26. doi: 10.1007/s12016-018-8672-5. [Epub ahead of print] Review.

PMID:
29372537
35.

Vaccinations in adults with rheumatoid arthritis in an era of new disease-modifying anti-rheumatic drugs.

Meroni PL, Zavaglia D, Girmenia C.

Clin Exp Rheumatol. 2018 Mar-Apr;36(2):317-328. Epub 2017 Dec 15. Review.

36.

Therapy for antiphospholipid miscarriages: Throwing the baby out with the bathwater?

Chighizola CB, Shoenfeld Y, Meroni PL.

Am J Reprod Immunol. 2018 Mar;79(3). doi: 10.1111/aji.12792. Epub 2017 Nov 28.

PMID:
29193441
37.

Oxidation of β2-glycoprotein I associates with IgG antibodies to domain I in patients with antiphospholipid syndrome.

Raimondo MG, Pericleous C, Radziszewska A, Borghi MO, Pierangeli S, Meroni PL, Giles I, Rahman A, Ioannou Y.

PLoS One. 2017 Oct 19;12(10):e0186513. doi: 10.1371/journal.pone.0186513. eCollection 2017.

38.

Serum chemerin in systemic sclerosis: a novel marker of early diffuse disease?

Chighizola CB, Raschi E, Privitera D, Luppino AF, Artusi C, Schioppo T, Mastaglio C, Ingegnoli F, Borghi MO, Meroni PL.

Clin Exp Rheumatol. 2017 Sep-Oct;35 Suppl 106(4):223-224. Epub 2017 Sep 29. No abstract available.

PMID:
28980906
39.

Flares After Withdrawal of Biologic Therapies in Juvenile Idiopathic Arthritis: Clinical and Laboratory Correlates of Remission Duration.

Simonini G, Ferrara G, Pontikaki I, Scoccimarro E, Giani T, Taddio A, Meroni PL, Cimaz R.

Arthritis Care Res (Hoboken). 2018 Jul;70(7):1046-1051. doi: 10.1002/acr.23435. Epub 2018 Apr 24.

PMID:
28973842
40.

Clinical predictors of response and discontinuation of belimumab in patients with systemic lupus erythematosus in real life setting. Results of a large, multicentric, nationwide study.

Iaccarino L, Andreoli L, Bocci EB, Bortoluzzi A, Ceccarelli F, Conti F, De Angelis R, De Marchi G, De Vita S, Di Matteo A, Emmi G, Emmi L, Gatto M, Gerli R, Gerosa M, Govoni M, Larosa M, Meroni PL, Mosca M, Pazzola G, Reggia R, Saccon F, Salvarani C, Tani C, Zen M, Frigo AC, Tincani A, Doria A.

J Autoimmun. 2018 Jan;86:1-8. doi: 10.1016/j.jaut.2017.09.004. Epub 2017 Sep 19.

PMID:
28935492
41.

Can we withdraw anticoagulation in patients with antiphospholipid syndrome after seroconvertion?

Sciascia S, Coloma-Bazán E, Radin M, Bertolaccini ML, López-Pedrera C, Espinosa G, Meroni PL, Cervera R, Cuadrado MJ.

Autoimmun Rev. 2017 Nov;16(11):1109-1114. doi: 10.1016/j.autrev.2017.09.004. Epub 2017 Sep 9. Review.

PMID:
28899804
42.

Prevalence and Thrombotic Risk Assessment of Anti-β2 Glycoprotein I Domain I Antibodies: A Systematic Review.

Radin M, Cecchi I, Roccatello D, Meroni PL, Sciascia S.

Semin Thromb Hemost. 2018 Jul;44(5):466-474. doi: 10.1055/s-0037-1603936. Epub 2017 Aug 4. Review.

PMID:
28778105
43.

Inflammatory Joint Disorders and Neutrophilic Dermatoses: a Comprehensive Review.

Cugno M, Gualtierotti R, Meroni PL, Marzano AV.

Clin Rev Allergy Immunol. 2018 Apr;54(2):269-281. doi: 10.1007/s12016-017-8629-0. Review.

PMID:
28735350
44.

Limited cutaneous systemic sclerosis skin demonstrates distinct molecular subsets separated by a cardiovascular development gene expression signature.

Derrett-Smith EC, Martyanov V, Chighizola CB, Moinzadeh P, Campochiaro C, Khan K, Wood TA, Meroni PL, Abraham DJ, Ong VH, Lafyatis R, Whitfield ML, Denton CP.

Arthritis Res Ther. 2017 Jul 4;19(1):156. doi: 10.1186/s13075-017-1360-7.

45.

Real-life 10-year retention rate of first-line anti-TNF drugs for inflammatory arthritides in adult- and juvenile-onset populations: similarities and differences.

Favalli EG, Pontikaki I, Becciolini A, Biggioggero M, Ughi N, Romano M, Crotti C, Gattinara M, Gerloni V, Marchesoni A, Meroni PL.

Clin Rheumatol. 2017 Aug;36(8):1747-1755. doi: 10.1007/s10067-017-3712-8. Epub 2017 Jun 8.

PMID:
28597133
46.

Cutaneous Manifestations of ANCA-Associated Small Vessels Vasculitis.

Marzano AV, Raimondo MG, Berti E, Meroni PL, Ingegnoli F.

Clin Rev Allergy Immunol. 2017 Dec;53(3):428-438. doi: 10.1007/s12016-017-8616-5. Review.

PMID:
28578472
47.

Longterm Outcome of Patients with Primary Antiphospholipid Syndrome: A Retrospective Multicenter Study.

Taraborelli M, Reggia R, Dall'Ara F, Fredi M, Andreoli L, Gerosa M, Hoxha A, Massaro L, Tonello M, Costedoat-Chalumeau N, Cacoub P, Franceschini F, Meroni PL, Piette JC, Ruffatti A, Valesini G, Harris EN, Tincani A.

J Rheumatol. 2017 Aug;44(8):1165-1172. doi: 10.3899/jrheum.161364. Epub 2017 Jun 1.

PMID:
28572466
48.

Ixekizumab for the treatment of patients with active psoriatic arthritis and an inadequate response to tumour necrosis factor inhibitors: results from the 24-week randomised, double-blind, placebo-controlled period of the SPIRIT-P2 phase 3 trial.

Nash P, Kirkham B, Okada M, Rahman P, Combe B, Burmester GR, Adams DH, Kerr L, Lee C, Shuler CL, Genovese M; SPIRIT-P2 Study Group.

Lancet. 2017 Jun 10;389(10086):2317-2327. doi: 10.1016/S0140-6736(17)31429-0. Epub 2017 May 24.

PMID:
28551073
49.

Differences in serum and synovial CD4+ T cells and cytokine profiles to stratify patients with inflammatory osteoarthritis and rheumatoid arthritis.

Penatti A, Facciotti F, De Matteis R, Larghi P, Paroni M, Murgo A, De Lucia O, Pagani M, Pierannunzii L, Truzzi M, Ioan-Facsinay A, Abrignani S, Geginat J, Meroni PL.

Arthritis Res Ther. 2017 May 19;19(1):103. doi: 10.1186/s13075-017-1305-1.

50.

Does APS Impact Women's Fertility?

Chighizola CB, Raimondo MG, Meroni PL.

Curr Rheumatol Rep. 2017 Jun;19(6):33. doi: 10.1007/s11926-017-0663-7. Review.

PMID:
28470478

Supplemental Content

Loading ...
Support Center